Does RISANKIZUMAB-RZAA Cause Malaise? 1,022 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,022 reports of Malaise have been filed in association with RISANKIZUMAB-RZAA. This represents 1.6% of all adverse event reports for RISANKIZUMAB-RZAA.
1,022
Reports of Malaise with RISANKIZUMAB-RZAA
1.6%
of all RISANKIZUMAB-RZAA reports
20
Deaths
365
Hospitalizations
How Dangerous Is Malaise From RISANKIZUMAB-RZAA?
Of the 1,022 reports, 20 (2.0%) resulted in death, 365 (35.7%) required hospitalization, and 11 (1.1%) were considered life-threatening.
Is Malaise Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 1,022 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Malaise?
ADALIMUMAB (15,965)
ETANERCEPT (13,600)
METHOTREXATE (9,970)
TOFACITINIB (9,040)
SECUKINUMAB (8,570)
INFLIXIMAB (7,477)
RITUXIMAB (6,587)
PREGABALIN (6,320)
PREDNISONE (6,319)
ABATACEPT (6,251)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Malaise Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA